American Journal of Epidemiology Vol. 155, No. 2 : 153-158
Copyright © 2002 by The Johns Hopkins University School of Hygiene and Public Health
ORIGINAL CONTRIBUTIONS |
Estimation of Risk of Cancers before Occurrence of Acquired Immunodeficiency Syndrome in Persons Infected with Human Immunodeficiency Virus
From the National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia.
There is methodological debate as to whether cohorts defined by acquired immunodeficiency syndrome (AIDS) diagnosis can be used to estimate risks of cancer in persons with human immunodeficiency virus (HIV) before AIDS. The authors compared risks of non-AIDS-defining cancers before AIDS in persons with HIV using a cohort based on AIDS diagnosis and a second cohort based on HIV diagnosis. National population-based registries of AIDS and HIV diagnoses to August 1999 were matched separately with the National Cancer Registry in Australia. Four analyses were performed. In analysis 1, follow-up was from 5 years before AIDS registration in 8,118 persons with AIDS. Analysis 2 was similar but adjusted expected numbers of cancers for decreased survival. Analysis 3 was based on 7,061 persons registered with HIV, with follow-up from the reported date of diagnosis. Analysis 4 was based on 2,112 AIDS cases previously reported with HIV, with follow-up from 5 years before AIDS diagnosis. In all analyses, follow-up ended at cancer diagnosis, death, 6 months before AIDS, or the end of available cancer data, whichever occurred first. For 10 types of cancer there were at least three cases in any one of the analyses. For these cancers there was no systematic pattern such that one analysis produced consistently higher or lower estimates than the others. These analyses suggest that cancer risk in persons with HIV before AIDS diagnosis may be estimated reliably based on cancer experience 5 years before AIDS.
acquired immunodeficiency syndrome; HIV infections; neoplasms
Abbreviations: AIDS, acquired immunodeficiency syndrome; CI, confidence interval; HIV, human immunodeficiency virus
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. Abali, G. Abali, and S. Aksoy Which One Is Better: AIDS Related or HIV Associated? J. Clin. Oncol., February 20, 2007; 25(6): e6 - e6. [Full Text] [PDF] |
||||
![]() |
C. M. Vajdic, S. P. McDonald, M. R. E. McCredie, M. T. van Leeuwen, J. H. Stewart, M. Law, J. R. Chapman, A. C. Webster, J. M. Kaldor, and A. E. Grulich Cancer Incidence Before and After Kidney Transplantation JAMA, December 20, 2006; 296(23): 2823 - 2831. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Clifford, J. Polesel, M. Rickenbach, on behalf of the Swiss HIV Cohort Study, L. Dal Maso, O. Keiser, A. Kofler, E. Rapiti, F. Levi, G. Jundt, et al. Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral Therapy J Natl Cancer Inst, March 16, 2005; 97(6): 425 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Engels, M. Frisch, R. J. Biggar, and J. J. Goedert RE: "ESTIMATION OF RISK OF CANCERS BEFORE OCCURRENCE OF ACQUIRED IMMUNODEFICIENCY SYNDROME IN PERSONS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS" Am. J. Epidemiol., May 15, 2003; 157(10): 955 - 955. [Full Text] [PDF] |
||||
![]() |
A. E. Grulich and M. G. Law TWO AUTHORS REPLY Am. J. Epidemiol., May 15, 2003; 157(10): 955 - 956. [Full Text] [PDF] |
||||



